🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the producers of Tylenol, alleging the corporations concealed safety concerns that the drug posed to children's cognitive development.

This legal action comes four weeks after Former President Trump advocated an unproven link between taking acetaminophen - referred to as paracetamol - while pregnant and autism spectrum disorder in offspring.

Paxton is taking legal action against the pharmaceutical giant, which previously sold the medication, the sole analgesic recommended for women during pregnancy, and Kenvue, which presently makes it.

In a official comment, he said they "misled consumers by gaining financially from suffering and marketing drugs ignoring the dangers."

The company says there is insufficient reliable data linking acetaminophen to autism.

"These manufacturers lied for decades, knowingly endangering numerous people to line their pockets," Paxton, from the Republican party, said.

Kenvue said in a statement that it was "very worried by the perpetuation of misinformation on the reliability of paracetamol and the likely effects that could have on the well-being of American women and children."

On its website, Kenvue also stated it had "regularly reviewed the pertinent research and there is no credible data that shows a verified association between taking paracetamol and autism spectrum disorder."

Associations speaking for physicians and healthcare providers share this view.

The American College of Obstetricians and Gynecologists has said acetaminophen - the primary component in acetaminophen - is one of the few options for expectant mothers to manage pain and fever, which can pose significant medical dangers if not addressed.

"In more than two decades of investigation on the consumption of acetaminophen in gestation, no reliable research has definitively established that the use of acetaminophen in any stage of gestation leads to neurological conditions in children," the group stated.

The court filing references current declarations from the former administration in asserting the drug is potentially dangerous.

Recently, the former president raised alarms from medical authorities when he told pregnant women to "resist strongly" not to use acetaminophen when unwell.

The US Food and Drug Administration then published an announcement that medical professionals should think about restricting the consumption of Tylenol, while also mentioning that "a direct connection" between the drug and autism in young ones has remains unverified.

The Health Department head Kennedy, who manages the Food and Drug Administration, had vowed in April to undertake "a massive testing and research effort" that would identify the origin of autism spectrum disorder in a short period.

But authorities advised that finding a single cause of autism spectrum disorder - thought by researchers to be the result of a complex mix of inherited and surrounding conditions - would prove challenging.

Autism spectrum disorder is a category of enduring cognitive variation and disability that impacts how persons perceive and interact with the surroundings, and is identified using medical professional evaluations.

In his court filing, the attorney general - who supports Trump who is campaigning for federal office - asserts Kenvue and J&J "willfully ignored and sought to suppress the research" around paracetamol and autism spectrum disorder.

The case seeks to make the firms "remove any commercial messaging" that claims acetaminophen is safe for expectant mothers.

This legal action mirrors the complaints of a collection of guardians of minors with autism spectrum disorder and ADHD who sued the makers of Tylenol in 2022.

Judicial authorities rejected the legal action, saying studies from the parents' expert witnesses was lacking definitive proof.